Pathophysiological mechanisms of liver injury in COVID-19

Alexander D Nardo1, Mathias Schneeweiss-Gleixner2, May Bakail3

  • 1Hans Popper Laboratory of Molecular Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Insights

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) can cause liver injury in COVID-19 patients. This liver involvement may indicate disease severity and predict acute respiratory distress syndrome (ARDS).

Area of Science:

  • Hepatology
  • Virology
  • Pulmonology

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to a global pandemic.
  • Acute respiratory distress syndrome (ARDS) is a primary cause of mortality in COVID-19 patients.
  • Hepatic involvement in COVID-19, while not causing liver failure without pre-existing conditions, correlates with disease severity and ARDS prognosis.

Purpose of the Study:

  • To review the pathophysiological mechanisms of SARS-CoV-2 hepatic tropism.
  • To discuss the spectrum of acute and potential long-term liver injury in COVID-19.
  • To explore the relationship between COVID-19 and liver dysfunction.

Main Methods:

  • Literature review of studies on COVID-19 and liver injury.
  • Analysis of potential mechanisms including direct viral infection, systemic inflammation, hypoxia, and iatrogenic factors.
  • Synthesis of current understanding of SARS-CoV-2's impact on the liver.

Main Results:

  • SARS-CoV-2 can affect the liver through various pathways.
  • Liver injury in COVID-19 ranges from direct infection to indirect effects of systemic illness.
  • Hepatic involvement serves as a potential prognostic marker for ARDS development.

Conclusions:

  • COVID-19 can lead to diverse forms of liver injury.
  • Understanding SARS-CoV-2's hepatic tropism is crucial for patient management.
  • Further research is needed to fully elucidate long-term hepatic consequences of COVID-19.

Related Concept Videos

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.0K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
92
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
114
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
935
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
4.3K